by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
Evaluation of the Benefit of Ropeginterferon Treatment in Patients with Polycythemia Vera Diana GRASU, Viola Maria POPOV, Mirela VOICU, Mihaela POPESCU, Oana PATRINOIU, Felicia MIHAI, Geanina OFITERU, Meilin OMER, Mihaela ANDREESCU Results: Twenty-three patients (15...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question Catalina GURAN, Mieta-Gabriela HATEGAN, Dacian Nicolae OROS, Despina CALAMAR-POPOVICI, Marioara IONITA HORTENSIA, Claudiu IONITA, Florica...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
Antiphospholipid Antibodies in Non-Hodgkin’s Lymphoma Sanda BURUIANA, Maria ROBU, Victor TOMACINSCHII, Minodora MAZUR, Lucia MAZUR-NICORICI Introduction: Non-Hodgkin’s lymphomas (NHL) are a heterogeneous group of malignant lymphoid tumors. Anticardiolipin...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
17p13.1 Deletion in Small B-cell Lymphocytic Lymphomas: A Prognostic Factor and Diagnostic Approach Andreea-Georgiana STOICA, Miruna CRISTIAN, Mariana ASCHIE, Anca-Florentina MITROI, Georgiana-Camelia COZARU, Gabriela-Izabela BALTATESCU, Mădălina BOSOTEANU1,...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
DRD vs. D-VCD in Newly Diagnosed AL Amyloidosis: A Retrospective Single-Center Study Larisa ZIDARU, Andreea JERCAN, Sinziana BARBU, Daniel Nicolae MURARIU, Daniel CORIU, Sorina Nicoleta BADELITA Aim: This study evaluates hematologic responses in AL amyloidosis...